Introduction: The objective of the current research was to develop and assess orodispersible tablets containing Cinnarizine, aimed at enhancing patient adherence among individuals dealing with Motion Sickness, particularly those who suffer from dizziness, nausea, and vomiting during Traveling in various modes of transportation such as car, airplane, boat, or even experiencing amusement park rides can induce feelings of nausea.This specific patient group necessitates a drug delivery system that is both quick and easy to swallow